TrialJournal of gastrointestinal cancer2022

Phase II Prospective Study of Trastuzumab in Combination with S-1 and Oxaliplatin (SOX100) Therapy for HER2-Positive Advanced Gastric Cancer.

Yoshinori Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.